Foresite Capital Management Iv, LLC Gritstone Bio, Inc. Transaction History

Foresite Capital Management Iv, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 13, 2019	SELL	$11.61 - $31.1 $2.03 Million - $5.44 Million	-175,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$14.24 - $14.24 $2.49 Million - $2.49 Million	175,000 New	175,000 $2.49 Million

37.5M

1.46M

168K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $1.46M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.